PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt
Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease and cancer. PIK3IP1 (or transmembrane inhibitor of PI3K [TrIP]) is a putative transmembrane regulator of PI3K. TrIP contains an extracellular...
Saved in:
Published in | The Journal of experimental medicine Vol. 215; no. 12; pp. 3165 - 3179 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Rockefeller University Press
03.12.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease and cancer. PIK3IP1 (or transmembrane inhibitor of PI3K [TrIP]) is a putative transmembrane regulator of PI3K. TrIP contains an extracellular kringle domain and an intracellular domain with homology to the inter-SH2 domain of the PI3K regulatory subunit p85, but the mechanism of TrIP function is poorly understood. We show that both the kringle and p85-like domains are necessary for TrIP inhibition of PI3K and that TrIP is down-modulated from the surface of T cells during T cell activation. In addition, we present evidence that the kringle domain may modulate TrIP function by mediating oligomerization. Using an inducible knockout mouse model, we show that TrIP-deficient T cells exhibit more robust activation and can mediate clearance of
infection faster than WT mice. Thus, TrIP is a negative regulator of T cell activation and may represent a novel target for immune modulation. |
---|---|
AbstractList | Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease and cancer. PIK3IP1 (or transmembrane inhibitor of PI3K [TrIP]) is a putative transmembrane regulator of PI3K. TrIP contains an extracellular kringle domain and an intracellular domain with homology to the inter-SH2 domain of the PI3K regulatory subunit p85, but the mechanism of TrIP function is poorly understood. We show that both the kringle and p85-like domains are necessary for TrIP inhibition of PI3K and that TrIP is down-modulated from the surface of T cells during T cell activation. In addition, we present evidence that the kringle domain may modulate TrIP function by mediating oligomerization. Using an inducible knockout mouse model, we show that TrIP-deficient T cells exhibit more robust activation and can mediate clearance of Listeria monocytogenes infection faster than WT mice. Thus, TrIP is a negative regulator of T cell activation and may represent a novel target for immune modulation. This study demonstrates a role for the transmembrane regulator of PI3K (TrIP) in restricting early T cell activation, at least in part through effects on PI3K. It is also shown that levels of TrIP decrease preceding full T cell activation. Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease and cancer. PIK3IP1 (or transmembrane inhibitor of PI3K [TrIP]) is a putative transmembrane regulator of PI3K. TrIP contains an extracellular kringle domain and an intracellular domain with homology to the inter-SH2 domain of the PI3K regulatory subunit p85, but the mechanism of TrIP function is poorly understood. We show that both the kringle and p85-like domains are necessary for TrIP inhibition of PI3K and that TrIP is down-modulated from the surface of T cells during T cell activation. In addition, we present evidence that the kringle domain may modulate TrIP function by mediating oligomerization. Using an inducible knockout mouse model, we show that TrIP-deficient T cells exhibit more robust activation and can mediate clearance of Listeria monocytogenes infection faster than WT mice. Thus, TrIP is a negative regulator of T cell activation and may represent a novel target for immune modulation. Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease and cancer. PIK3IP1 (or transmembrane inhibitor of PI3K [TrIP]) is a putative transmembrane regulator of PI3K. TrIP contains an extracellular kringle domain and an intracellular domain with homology to the inter-SH2 domain of the PI3K regulatory subunit p85, but the mechanism of TrIP function is poorly understood. We show that both the kringle and p85-like domains are necessary for TrIP inhibition of PI3K and that TrIP is down-modulated from the surface of T cells during T cell activation. In addition, we present evidence that the kringle domain may modulate TrIP function by mediating oligomerization. Using an inducible knockout mouse model, we show that TrIP-deficient T cells exhibit more robust activation and can mediate clearance of infection faster than WT mice. Thus, TrIP is a negative regulator of T cell activation and may represent a novel target for immune modulation. |
Author | Kataoka, Shunsuke Grebinoski, Stephanie J D'Cruz, Louise M Kane, Lawrence P Uche, Uzodinma U Piccirillo, Ann R |
AuthorAffiliation | 3 Asahi Kasei Pharma Corporation, Tokyo, Japan 4 Graduate Program in Microbiology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 2 Interdisciplinary Biomedical Graduate Program, University of Pittsburgh School of Medicine, Pittsburgh, PA 1 Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA |
AuthorAffiliation_xml | – name: 4 Graduate Program in Microbiology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA – name: 1 Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA – name: 2 Interdisciplinary Biomedical Graduate Program, University of Pittsburgh School of Medicine, Pittsburgh, PA – name: 3 Asahi Kasei Pharma Corporation, Tokyo, Japan |
Author_xml | – sequence: 1 givenname: Uzodinma U orcidid: 0000-0002-9397-8117 surname: Uche fullname: Uche, Uzodinma U organization: Interdisciplinary Biomedical Graduate Program, University of Pittsburgh School of Medicine, Pittsburgh, PA – sequence: 2 givenname: Ann R surname: Piccirillo fullname: Piccirillo, Ann R organization: Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA – sequence: 3 givenname: Shunsuke surname: Kataoka fullname: Kataoka, Shunsuke organization: Asahi Kasei Pharma Corporation, Tokyo, Japan – sequence: 4 givenname: Stephanie J surname: Grebinoski fullname: Grebinoski, Stephanie J organization: Graduate Program in Microbiology and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA – sequence: 5 givenname: Louise M orcidid: 0000-0003-0388-430X surname: D'Cruz fullname: D'Cruz, Louise M organization: Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA – sequence: 6 givenname: Lawrence P orcidid: 0000-0001-5198-516X surname: Kane fullname: Kane, Lawrence P email: lkane@pitt.edu organization: Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA lkane@pitt.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30429249$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkDtPwzAUhS1URB-wMaOMDKT1K4m9IFUVj6iVyFBmy3GcxiWNi51W4t-Tqg_BcHWHc3TuPd8Q9BrbaADuERwjyOhkrTdjDFHSDbsCAxRRGPKIsB4YQIhxiCBM-mDo_RpCRGkU34A-gRRzTPkAzLN0TtIMTZYuzQKnfeuMan0gVWv2sjW2CWwZLAOl69oHbeXsblUFpqlMbs5qlpL5ZPrV3oLrUtZe3532CHy-vixn7-Hi4y2dTRehIoy2Ics1U1zyQnLKk-7zHKtSlzxHJYwLxcoCskgzRjQsNClUzLQmPGZ5UTClSkJG4PmYu93lG10o3bRO1mLrzEa6H2GlEf-VxlRiZfcixgmnMO4CHk8Bzn7vus5iY_yhoWy03XmBESEM04jyzvp0tCpnvXe6vJxBUBz4i46_OPPv7A9_X7uYz8DJLzo5g2Y |
CitedBy_id | crossref_primary_10_1007_s00280_022_04493_5 crossref_primary_10_26508_lsa_202201683 crossref_primary_10_3390_ani10101924 crossref_primary_10_1016_j_ejphar_2024_176753 crossref_primary_10_3390_ijms20235841 crossref_primary_10_1126_sciimmunol_abm0631 crossref_primary_10_1158_1078_0432_CCR_18_4134 crossref_primary_10_1016_j_omtm_2021_09_019 crossref_primary_10_1126_sciadv_abo4250 crossref_primary_10_3390_cells11142162 crossref_primary_10_1126_science_abo2296 crossref_primary_10_1111_all_15819 crossref_primary_10_33396_1728_0869_2021_10_21_28 crossref_primary_10_12688_f1000research_26928_1 crossref_primary_10_3390_ijms22094969 crossref_primary_10_3390_cancers13235912 crossref_primary_10_1038_s41422_020_0301_1 crossref_primary_10_3389_fonc_2022_1042196 crossref_primary_10_4049_jimmunol_2000584 crossref_primary_10_1016_j_jbior_2020_100722 crossref_primary_10_1038_s41598_022_15230_6 crossref_primary_10_1084_jem_20202084 crossref_primary_10_3390_pathogens11080822 crossref_primary_10_1016_j_ccell_2021_02_007 crossref_primary_10_1158_2326_6066_CIR_22_0702 crossref_primary_10_1038_s41598_020_66224_1 crossref_primary_10_1016_j_phymed_2024_155608 |
Cites_doi | 10.1021/bi100687f 10.1038/nri3198 10.1111/j.1600-065X.1986.tb01501.x 10.4049/jimmunol.149.7.2255 10.1146/annurev.biochem.67.1.481 10.1038/nri3278 10.1096/fasebj.12.15.1731 10.1038/onc.2008.247 10.1002/eji.201141653 10.1016/0014-5793(84)80473-1 10.1038/nrc2664 10.1016/j.bbrc.2007.04.096 10.1042/BST0350177 10.1038/sj.emboj.7601520 10.1073/pnas.1005183107 10.1073/pnas.0800928105 10.3389/fimmu.2012.00245 10.18632/oncotarget.260 10.1042/bst0310270 10.1128/JVI.00006-15 10.1016/j.ctrv.2003.07.007 10.4049/jimmunol.173.11.6806 10.1084/jem.20171820 10.1016/S1074-7613(03)00081-5 10.1158/0008-5472.CAN-08-0025 10.4049/jimmunol.1402554 10.1159/000147844 10.1038/nri1461 10.1038/ng.2846 10.1038/nature04606 10.1111/imr.12148 10.3389/fimmu.2012.00151 10.1016/j.immuni.2011.01.012 10.1021/bi00005a003 10.1016/0092-8674(91)90314-O 10.1016/j.mib.2003.12.002 10.1074/jbc.M109.041715 10.1126/science.296.5573.1655 10.2174/1568011023353705 10.4049/jimmunol.0903170 10.2174/1389450114666140106100909 10.4049/jimmunol.172.9.5441 10.1146/annurev-immunol-032712-095946 |
ContentType | Journal Article |
Copyright | 2018 Uche et al. 2018 Uche et al. 2018 |
Copyright_xml | – notice: 2018 Uche et al. – notice: 2018 Uche et al. 2018 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1084/jem.20172018 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | TrIP regulates T cell activation |
EISSN | 1540-9538 |
EndPage | 3179 |
ExternalDocumentID | 10_1084_jem_20172018 30429249 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R21 AI126845 – fundername: NIAID NIH HHS grantid: R01 AI103022 – fundername: NIAID NIH HHS grantid: R21 AI095730 – fundername: NIH HHS grantid: S10 OD011925 – fundername: ; – fundername: PHS grantid: S10OD011925 – fundername: Public Health Service grantid: AI126845; AI095730 – fundername: PHS grantid: AI103022 |
GroupedDBID | --- -~X 18M 29K 2WC 36B 4.4 53G 5GY 5RE 5VS ABOCM ABZEH ACGFO ACNCT ACPRK ADBBV AENEX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C45 CGR CS3 CUY CVF D-I DIK DU5 E3Z EBS ECM EIF EJD EMB F5P F9R FRP GX1 H13 HYE IH2 K-O KQ8 L7B N9A NPM O5R O5S OK1 P2P P6G R.V RHF RHI RPM SJN TR2 TRP UHB W8F WOQ AAYXX CITATION 7X8 AFNDN 5PM |
ID | FETCH-LOGICAL-c384t-8be8c9a9da9497017b2cfef9b1f06dc8fd085e883e0de3dc68ee3968bdd8ccf33 |
IEDL.DBID | RPM |
ISSN | 0022-1007 |
IngestDate | Tue Sep 17 21:11:35 EDT 2024 Wed Jul 17 03:55:38 EDT 2024 Thu Sep 26 16:08:07 EDT 2024 Sat Sep 28 08:17:27 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
License | 2018 Uche et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c384t-8be8c9a9da9497017b2cfef9b1f06dc8fd085e883e0de3dc68ee3968bdd8ccf33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-5198-516X 0000-0002-9397-8117 0000-0003-0388-430X |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279406/ |
PMID | 30429249 |
PQID | 2133824549 |
PQPubID | 23479 |
PageCount | 15 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6279406 proquest_miscellaneous_2133824549 crossref_primary_10_1084_jem_20172018 pubmed_primary_30429249 |
PublicationCentury | 2000 |
PublicationDate | 20181203 |
PublicationDateYYYYMMDD | 2018-12-03 |
PublicationDate_xml | – month: 12 year: 2018 text: 20181203 day: 3 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of experimental medicine |
PublicationTitleAlternate | J Exp Med |
PublicationYear | 2018 |
Publisher | Rockefeller University Press |
Publisher_xml | – name: Rockefeller University Press |
References | Hedrick (2023072603554513500_bib21) 2012; 12 Kane (2023072603554513500_bib25) 2004; 172 Engelman (2023072603554513500_bib13) 2009; 9 Cerdan (2023072603554513500_bib7) 1992; 149 Li (2023072603554513500_bib28) 2007; 26 Okkenhaug (2023072603554513500_bib35) 2003; 31 Agoulnik (2023072603554513500_bib1) 2011; 2 Pamer (2023072603554513500_bib36) 2004; 4 Han (2023072603554513500_bib17) 2012; 3 Antignano (2023072603554513500_bib2) 2010; 184 Patthy (2023072603554513500_bib37) 1984; 171 Zhu (2023072603554513500_bib45) 2007; 358 He (2023072603554513500_bib20) 2008; 68 Wong (2023072603554513500_bib44) 2014; 46 Sauer (2023072603554513500_bib38) 2008; 105 Fresno Vara (2023072603554513500_bib14) 2004; 30 Cantley (2023072603554513500_bib3) 2002; 296 Mikels (2023072603554513500_bib31) 2009; 284 Castellino (2023072603554513500_bib6) 1997; 212 Fruman (2023072603554513500_bib16) 1998; 67 Shiow (2023072603554513500_bib39) 2006; 440 Chi (2023072603554513500_bib8) 2012; 12 Théry (2023072603554513500_bib41) 1996; 156 Wong (2023072603554513500_bib43) 2003; 18 Tolbert (2023072603554513500_bib42) 2010; 107 Fruman (2023072603554513500_bib15) 2007; 35 Carracedo (2023072603554513500_bib5) 2008; 27 Macintyre (2023072603554513500_bib29) 2011; 34 DeFrances (2023072603554513500_bib11) 2012; 42 Christen (2023072603554513500_bib9) 2010; 49 Cao (2023072603554513500_bib4) 2002; 2 Clayton (2023072603554513500_bib10) 2015; 89 Newton (2023072603554513500_bib32) 2012; 3 Okkenhaug (2023072603554513500_bib34) 2010; 346 Hawse (2023072603554513500_bib19) 2015; 194 Huynh (2023072603554513500_bib22) 2014; 258 Menhart (2023072603554513500_bib30) 1995; 34 Singh (2023072603554513500_bib40) 2018; 215 Dillon (2023072603554513500_bib12) 2014; 15 Okkenhaug (2023072603554513500_bib33) 2013; 31 Lara-Tejero (2023072603554513500_bib26) 2004; 7 Irving (2023072603554513500_bib23) 1991; 64 Ji (2023072603554513500_bib24) 1998; 12 Haughton (2023072603554513500_bib18) 1986; 93 Li (2023072603554513500_bib27) 2004; 173 |
References_xml | – volume: 49 start-page: 7131 year: 2010 ident: 2023072603554513500_bib9 article-title: Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape publication-title: Biochemistry. doi: 10.1021/bi100687f contributor: fullname: Christen – volume: 12 start-page: 325 year: 2012 ident: 2023072603554513500_bib8 article-title: Regulation and function of mTOR signalling in T cell fate decisions publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3198 contributor: fullname: Chi – volume: 93 start-page: 35 year: 1986 ident: 2023072603554513500_bib18 article-title: The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.1986.tb01501.x contributor: fullname: Haughton – volume: 212 start-page: 46 year: 1997 ident: 2023072603554513500_bib6 article-title: The kringle domains of human plasminogen publication-title: Ciba Found. Symp. contributor: fullname: Castellino – volume: 149 start-page: 2255 year: 1992 ident: 2023072603554513500_bib7 article-title: Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation publication-title: J. Immunol. doi: 10.4049/jimmunol.149.7.2255 contributor: fullname: Cerdan – volume: 67 start-page: 481 year: 1998 ident: 2023072603554513500_bib16 article-title: Phosphoinositide kinases publication-title: Annu. Rev. Biochem. doi: 10.1146/annurev.biochem.67.1.481 contributor: fullname: Fruman – volume: 12 start-page: 649 year: 2012 ident: 2023072603554513500_bib21 article-title: FOXO transcription factors throughout T cell biology publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3278 contributor: fullname: Hedrick – volume: 12 start-page: 1731 year: 1998 ident: 2023072603554513500_bib24 article-title: Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis publication-title: FASEB J. doi: 10.1096/fasebj.12.15.1731 contributor: fullname: Ji – volume: 27 start-page: 5527 year: 2008 ident: 2023072603554513500_bib5 article-title: The PTEN-PI3K pathway: of feedbacks and cross-talks publication-title: Oncogene. doi: 10.1038/onc.2008.247 contributor: fullname: Carracedo – volume: 42 start-page: 2754 year: 2012 ident: 2023072603554513500_bib11 article-title: Inhibition of T-cell activation by PIK3IP1 publication-title: Eur. J. Immunol. doi: 10.1002/eji.201141653 contributor: fullname: DeFrances – volume: 171 start-page: 131 year: 1984 ident: 2023072603554513500_bib37 article-title: Kringles: modules specialized for protein binding. Homology of the gelatin-binding region of fibronectin with the kringle structures of proteases publication-title: FEBS Lett. doi: 10.1016/0014-5793(84)80473-1 contributor: fullname: Patthy – volume: 9 start-page: 550 year: 2009 ident: 2023072603554513500_bib13 article-title: Targeting PI3K signalling in cancer: opportunities, challenges and limitations publication-title: Nat. Rev. Cancer. doi: 10.1038/nrc2664 contributor: fullname: Engelman – volume: 346 start-page: 57 year: 2010 ident: 2023072603554513500_bib34 article-title: PI3Ks in lymphocyte signaling and development publication-title: Curr. Top. Microbiol. Immunol. contributor: fullname: Okkenhaug – volume: 358 start-page: 66 year: 2007 ident: 2023072603554513500_bib45 article-title: PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2007.04.096 contributor: fullname: Zhu – volume: 35 start-page: 177 year: 2007 ident: 2023072603554513500_bib15 article-title: The role of class I phosphoinositide 3-kinase in T-cell function and autoimmunity publication-title: Biochem. Soc. Trans. doi: 10.1042/BST0350177 contributor: fullname: Fruman – volume: 26 start-page: 494 year: 2007 ident: 2023072603554513500_bib28 article-title: Metalloproteases regulate T-cell proliferation and effector function via LAG-3 publication-title: EMBO J. doi: 10.1038/sj.emboj.7601520 contributor: fullname: Li – volume: 107 start-page: 13264 year: 2010 ident: 2023072603554513500_bib42 article-title: Structural basis for agonism and antagonism of hepatocyte growth factor publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.1005183107 contributor: fullname: Tolbert – volume: 105 start-page: 7797 year: 2008 ident: 2023072603554513500_bib38 article-title: T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.0800928105 contributor: fullname: Sauer – volume: 3 start-page: 245 year: 2012 ident: 2023072603554513500_bib17 article-title: The Role of the PI3K Signaling Pathway in CD4(+) T Cell Differentiation and Function publication-title: Front. Immunol. doi: 10.3389/fimmu.2012.00245 contributor: fullname: Han – volume: 2 start-page: 321 year: 2011 ident: 2023072603554513500_bib1 article-title: INPP4B: the new kid on the PI3K block publication-title: Oncotarget. doi: 10.18632/oncotarget.260 contributor: fullname: Agoulnik – volume: 31 start-page: 270 year: 2003 ident: 2023072603554513500_bib35 article-title: PI3K-signalling in B- and T-cells: insights from gene-targeted mice publication-title: Biochem. Soc. Trans. doi: 10.1042/bst0310270 contributor: fullname: Okkenhaug – volume: 89 start-page: 3723 year: 2015 ident: 2023072603554513500_bib10 article-title: Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression publication-title: J. Virol. doi: 10.1128/JVI.00006-15 contributor: fullname: Clayton – volume: 30 start-page: 193 year: 2004 ident: 2023072603554513500_bib14 article-title: PI3K/Akt signalling pathway and cancer publication-title: Cancer Treat. Rev. doi: 10.1016/j.ctrv.2003.07.007 contributor: fullname: Fresno Vara – volume: 173 start-page: 6806 year: 2004 ident: 2023072603554513500_bib27 article-title: Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223) publication-title: J. Immunol. doi: 10.4049/jimmunol.173.11.6806 contributor: fullname: Li – volume: 215 start-page: 2429 year: 2018 ident: 2023072603554513500_bib40 article-title: B cell adaptor for PI3-kinase (BCAP) modulates CD8+ effector and memory T cell differentiation publication-title: J. Exp. Med. doi: 10.1084/jem.20171820 contributor: fullname: Singh – volume: 18 start-page: 499 year: 2003 ident: 2023072603554513500_bib43 article-title: Feedback regulation of pathogen-specific T cell priming publication-title: Immunity. doi: 10.1016/S1074-7613(03)00081-5 contributor: fullname: Wong – volume: 68 start-page: 5591 year: 2008 ident: 2023072603554513500_bib20 article-title: PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-08-0025 contributor: fullname: He – volume: 194 start-page: 4615 year: 2015 ident: 2023072603554513500_bib19 article-title: Cutting Edge: Differential Regulation of PTEN by TCR, Akt, and FoxO1 Controls CD4+ T Cell Fate Decisions publication-title: J. Immunol. doi: 10.4049/jimmunol.1402554 contributor: fullname: Hawse – volume: 156 start-page: 162 year: 1996 ident: 2023072603554513500_bib41 article-title: Roles of kringle domain-containing serine proteases in epithelial-mesenchymal transitions during embryonic development publication-title: Acta Anat. (Basel). doi: 10.1159/000147844 contributor: fullname: Théry – volume: 4 start-page: 812 year: 2004 ident: 2023072603554513500_bib36 article-title: Immune responses to Listeria monocytogenes publication-title: Nat. Rev. Immunol. doi: 10.1038/nri1461 contributor: fullname: Pamer – volume: 46 start-page: 33 year: 2014 ident: 2023072603554513500_bib44 article-title: Inactivating CUX1 mutations promote tumorigenesis publication-title: Nat. Genet. doi: 10.1038/ng.2846 contributor: fullname: Wong – volume: 440 start-page: 540 year: 2006 ident: 2023072603554513500_bib39 article-title: CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs publication-title: Nature. doi: 10.1038/nature04606 contributor: fullname: Shiow – volume: 258 start-page: 117 year: 2014 ident: 2023072603554513500_bib22 article-title: Signals and pathways controlling regulatory T cells publication-title: Immunol. Rev. doi: 10.1111/imr.12148 contributor: fullname: Huynh – volume: 3 start-page: 151 year: 2012 ident: 2023072603554513500_bib32 article-title: Regulation of T cell homeostasis and responses by pten publication-title: Front. Immunol. doi: 10.3389/fimmu.2012.00151 contributor: fullname: Newton – volume: 34 start-page: 224 year: 2011 ident: 2023072603554513500_bib29 article-title: Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism publication-title: Immunity. doi: 10.1016/j.immuni.2011.01.012 contributor: fullname: Macintyre – volume: 34 start-page: 1482 year: 1995 ident: 2023072603554513500_bib30 article-title: Roles of individual kringle domains in the functioning of positive and negative effectors of human plasminogen activation publication-title: Biochemistry. doi: 10.1021/bi00005a003 contributor: fullname: Menhart – volume: 64 start-page: 891 year: 1991 ident: 2023072603554513500_bib23 article-title: The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways publication-title: Cell. doi: 10.1016/0092-8674(91)90314-O contributor: fullname: Irving – volume: 7 start-page: 45 year: 2004 ident: 2023072603554513500_bib26 article-title: T cell responses to Listeria monocytogenes publication-title: Curr. Opin. Microbiol. doi: 10.1016/j.mib.2003.12.002 contributor: fullname: Lara-Tejero – volume: 284 start-page: 30167 year: 2009 ident: 2023072603554513500_bib31 article-title: Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109.041715 contributor: fullname: Mikels – volume: 296 start-page: 1655 year: 2002 ident: 2023072603554513500_bib3 article-title: The phosphoinositide 3-kinase pathway publication-title: Science. doi: 10.1126/science.296.5573.1655 contributor: fullname: Cantley – volume: 2 start-page: 667 year: 2002 ident: 2023072603554513500_bib4 article-title: Kringle structures and antiangiogenesis publication-title: Curr. Med. Chem. Anticancer Agents. doi: 10.2174/1568011023353705 contributor: fullname: Cao – volume: 184 start-page: 2805 year: 2010 ident: 2023072603554513500_bib2 article-title: SHIP is required for dendritic cell maturation publication-title: J. Immunol. doi: 10.4049/jimmunol.0903170 contributor: fullname: Antignano – volume: 15 start-page: 65 year: 2014 ident: 2023072603554513500_bib12 article-title: Therapeutic targeting of cancers with loss of PTEN function publication-title: Curr. Drug Targets. doi: 10.2174/1389450114666140106100909 contributor: fullname: Dillon – volume: 172 start-page: 5441 year: 2004 ident: 2023072603554513500_bib25 article-title: A proline-rich motif in the C terminus of Akt contributes to its localization in the immunological synapse publication-title: J. Immunol. doi: 10.4049/jimmunol.172.9.5441 contributor: fullname: Kane – volume: 31 start-page: 675 year: 2013 ident: 2023072603554513500_bib33 article-title: Signaling by the phosphoinositide 3-kinase family in immune cells publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev-immunol-032712-095946 contributor: fullname: Okkenhaug |
SSID | ssj0014456 |
Score | 2.4599752 |
Snippet | Phosphatidylinositol-3 kinases (PI3Ks) modulate cellular growth, proliferation, and survival; dysregulation of the PI3K pathway can lead to autoimmune disease... This study demonstrates a role for the transmembrane regulator of PI3K (TrIP) in restricting early T cell activation, at least in part through effects on PI3K.... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 3165 |
SubjectTerms | Animals Carrier Proteins - genetics Carrier Proteins - immunology Class Ia Phosphatidylinositol 3-Kinase - genetics Class Ia Phosphatidylinositol 3-Kinase - immunology HEK293 Cells Humans Intracellular Signaling Peptides and Proteins Listeria monocytogenes - immunology Listeriosis - genetics Listeriosis - immunology Listeriosis - pathology Lymphocyte Activation Membrane Proteins Mice Mice, Transgenic T-Lymphocytes - immunology T-Lymphocytes - pathology |
Title | PIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30429249 https://search.proquest.com/docview/2133824549 https://pubmed.ncbi.nlm.nih.gov/PMC6279406 |
Volume | 215 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT4QwEJ7oHowX41t8bGqiR-TRAuW4MW7EzRoOa-KN0HYa8cEaF_-_LQvG1ZvnAmm_TpjXNzMAF1SIkoVauCVX6LKAa5dT5bspJtKIR6S4tAH96X18-8DuHqPHNYj6WpiWtC9FdVW_vl3V1VPLrXx_k17PE_Py6XUcGinyY28d1hNKexe9Sx0w1o5sbWnqlgLQsd19zrxntLXnRmX7gZ3TZz15636sqqQ_duZvuuQP_TPehq3OcCSj5QZ3YA3rXdiYdqnxPZjk2YRmeeDNPrKc2Ikb5g_XLIgtXFiGXclckxmxkfoF6cbzkKp-qkTVr-YZnXijl2YfHsY3s-tbt5uU4ErKWeNygVymZarKlKWJOaEIpUadikD7sZJcK2NZIecUfYVUyZgj0jTmQpm7kJrSAxjU8xqPgKDgZckSrRMmGdOhSMJIREpHKXKMdODAZQ9W8b5siFG0iWzOCoNv0ePrwHmPZGEk1h6urHH-uShC6xaHzDimDhwukf3-Un8lDiQrmH8_YLthr64YIWm7YndCcfzvN09g02685arQUxg0H594ZiyORgyNrZ1Nhq2cfQH9adeV |
link.rule.ids | 230,315,733,786,790,891,27957,27958,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkGgv5dHSbgutkdpjNg87iXNECLRhWZTDUnGLYnssUkoWsdlLf33tJEYsPbVnJ1Em3zgz4_lmBuAbFaJikRZexRV6LOTa41QFXoapNOoRKy7tgf7sKplcs4ub-GYDYlcL05H2pajHza_7cVPfdtzKh3vpO56YX8xOk8hoUZD4r2DL7NcodUH6kDxgrBva2hHVLQlg4LsHnPk_0VafG6MdhHZSn43lbQCybpT-8jRfEiafWaDzHfjh3r0nntyNV60Yy98v2jr-s3C78HbwSclJv7wHG9jsw_ZsyLq_g2mRT2lehP78MS-IHeZhfp7tktiaiP5Elyw0mRObBFiSYfIPqZvbWtRutcjp1D-5a9_D9fnZ_HTiDUMYPEk5az0ukMusylSVsSw1n05EUqPORKiDREmulXHakHOKgUKqZMIRaZZwoQzMUlN6AJvNosGPQFDwqmKp1imTjOlIpFEsYqXjDDnGOhzBd4dC-dD32ii7HDlnpQGudMCN4NhBVJrNYIWrGlyslmVkI-6ImZh3BB96yJ6e5LAeQboG5tMFttH2-oqBqGu4PUDy6b_v_AqvJ_PZZXmZX00_wxsrREeJoYew2T6u8Mg4Nq340qnxHx3P-JY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkFAvFPqA7QNcqT1m87CT2EcEXRG2i3JYJNRLFNtjkVKyKzZ76a-vnQdi6Y2zHSuTb5yZ8XyeAfhGpSxZZKRXco0eC7nxONWBJzBVVj1izZU70J9dJRfX7PImvnnS6qsl7StZjes_9-O6um25lct75Q88MT-fnSWR1aIg8Zfa-K9gx-7ZSAyBep9AYKxt3NqS1R0RoOe8B5z5v9HdQLeGOwhdtz4Xz7sgZNMw_edtPidNPrFCkzfwa3j_jnxyN143cqz-Pivt-CIB92Gv903JaTflALawfgu7sz77_g6meTalWR7684csJ66ph_2JNivi7kZ0J7tkYcicuGTAivQdgEhV31ayGkbzjE7907vmPVxPfszPLry-GYOnKGeNxyVyJUqhS8FEaj-fjJRBI2RogkQrbrR13pBzioFGqlXCEalIuNQWbmUo_QDb9aLGIyAoeVmy1JiUKcZMJNMolrE2sUCOsQlH8H1Aolh2NTeKNlfOWWHBKwbwRvB1gKmwm8IJV9a4WK-KyEXeEbOx7wgOO9geVxrwHkG6AejjBFdwe3PEwtQW3u5h-fjiJ09gNz-fFD-zq-kneO1kaJkx9DNsNw9r_GL9m0Yet5r8D_GC-xY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PIK3IP1%2FTrIP+restricts+activation+of+T+cells+through+inhibition+of+PI3K%2FAkt&rft.jtitle=The+Journal+of+experimental+medicine&rft.au=Uche%2C+Uzodinma+U&rft.au=Piccirillo%2C+Ann+R&rft.au=Kataoka%2C+Shunsuke&rft.au=Grebinoski%2C+Stephanie+J&rft.date=2018-12-03&rft.eissn=1540-9538&rft.volume=215&rft.issue=12&rft.spage=3165&rft_id=info:doi/10.1084%2Fjem.20172018&rft_id=info%3Apmid%2F30429249&rft.externalDocID=30429249 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1007&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1007&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1007&client=summon |